Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Eylea Biosimilar Race Hots Up As Formycon Launches Phase III Trials
Formycon Collaborating With Partner Bioeq
Aug 24 2020
•
By
Dean Rudge
Eylea represents one of the largest biological opportunities in the world. • Source: Shutterstock
More from Products
More from Generics Bulletin